In this episode, I’ll discuss advice given by AHA and ACC Presidents on QTc interaction between hydroxychloroquine and azithromycin. Subscribe on iTunes, Android, or Stitcher As discussed in episode 488, there is tremendous interest in combining hydroxychloroquine and azithromycin for the treatment of COVID-19 based on a small French observational study. Performing a risk:benefit analysis […]
A free twice-weekly podcast where you can listen to critical care and hospital pharmacy information
Subscribe to the #1 ranked critical care and hospital pharmacy podcast, The Elective Rotation here:
Episode 494: What to use for acute asthma exacerbation if you run out of MDIs?
In this episode, I’ll discuss what to use for acute asthma exacerbation if you run out of MDIs and can’t use nebulizers. Subscribe on iTunes, Android, or Stitcher Many hospitals are prohibiting nebulizer use during the COVID-19 pandemic to protect staff from disease transmission during this aerosol-generating procedure. This has led to the increased use […]
Episode 493: Can hydromorphone infusion be used in ventilated ICU patients?
In this episode, I’ll discuss whether hydromorphone can be used as a continuous infusion in place of fentanyl for ICU patients on a ventilator. Subscribe on iTunes, Android, or Stitcher Some hospitals are being faced with supply shortages of critical medications such as fentanyl, and are faced with using less ideal alternatives for continuous sedation […]
Episode 492: Do unused and unopened medications that have been in COVID-19 patient rooms need to be discarded?
In this episode, I’ll discuss the CDC Guideline for Disinfection and Sterilization in Healthcare Facilities and how it may pertain to unused and unopened medications that have been in COVID-19 patient rooms. Subscribe on iTunes, Android, or Stitcher Avoiding bringing medications into rooms with COVID-19 patients until they are ready to be used is the […]
Episode 491: Pharmacy-related COVID-19 updates
In this episode, I’ll discuss pharmacy-related COVID-19 updates. Subscribe on iTunes, Android, or Stitcher Hydroxychloroquine and chloroquine FDA Emergency Use Authorization The FDA has issued an Emergency Use Authorization for hydroxychloroquine and chloroquine to be used in patients with COVID-19. The FDA has also prepared patient and health care provider fact sheets. If you are […]
Episode 490: Which vasopressor should be discontinued first?
In this episode, I’ll discuss the discontinuation order of vasopressors. Subscribe on iTunes, Android, or Stitcher The first two vasopressors generally used to treat septic shock are norepinephrine and vasopressin. The usual strategy is to add vasopressin to norepinephrine. But what happens when the patient recovers and vasopressors need to be weaned? There is little […]
Episode 489: Pharmacy-related recommendations from the surviving sepsis COVID-19 critical care guidelines
In this episode, I’ll discuss pharmacy-related recommendations from the surviving sepsis COVID-19 critical care guidelines. Subscribe on iTunes, Android, or Stitcher The Surviving Sepsis Campaign has published guidelines on the management of critically ill adults with COVID-19. These guidelines were last updated on March 20th 2020. Information and recommendations are changing rapidly in this area […]
Bonus Episode 488: Evaluating the unknown QTc/torsades risk of hydroxychloroquine and azithromycin
In this episode, I’ll discuss evaluating the unknown QTc/torsades risk of hydroxychloroquine and azithromycin. Subscribe on iTunes, Android, or Stitcher In a small case-control study, the combination of hydroxychloroquine and azithromycin appeared to reduce nasopharyngeal carriage of the COVID-19 virus. In vitro studies also suggest that hydroxychloroquine would have efficacy against this virus. While the […]
Episode 487: What is the difference between DKA and HHS?
In this episode, I’ll discuss the difference between DKA and HHS. Subscribe on iTunes, Android, or Stitcher Definition Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are the most serious acute complications of diabetes. These diabetic crises cause thousands of deaths annually in the US. DKA and HHS differ clinically according to the presence of ketoacidosis […]
Episode 486: Medications that have in vitro but otherwise unproven activity against COVID-19
In this episode, I’ll discuss medications that have in vitro but otherwise unproven activity against COVID-19. Subscribe on iTunes, Android, or Stitcher Do you want Monday’s podcast episode to be about meds that have in vitro but otherwise unproven activity against COVID-19 or some other topic that has nothing to do with COVID-19? — Pharmacy […]
Episode 485: Can etomidate be given as a continuous infusion?
In this episode, I’ll discuss whether etomidate can be given as a continuous infusion. Subscribe on iTunes, Android, or Stitcher Etomidate is a non-barbituate, general anesthetic agent. By far the most common use for etomidate in ICU patients is as an induction agent during rapid sequence intubation. Etomidate would be effective at providing sedation as […]
Episode 484: Top takeways for hospital pharmacists from the NEJM editors discussion on treating Covid-19
In this episode, I’ll discuss a recent discussion hosted by 2 editors of NEJM on treating Covid-19. Subscribe on iTunes, Android, or Stitcher On March 5th Doctors Eric Rubin and Lindsey Baden, two editors for the New England Journal of Medicine, published a discussion on the treatment of patients with the Covid-19 virus. Although the […]
- « Previous Page
- 1
- …
- 39
- 40
- 41
- 42
- 43
- …
- 81
- Next Page »